Role of adipokines and inflammatory markers in postmenopausal hypertension

Minerva Endocrinologica

Volumn 43, Issue 2, 2018, Pages 101-108

  July, Mose ^a   Faiz, Saba ^a,b   Yaqub, Abid ^a,c   Santhanam, Prasanna ^a,d   Douglas, Jillian ^a   Stanek, Ronald ^a   Gress, Todd ^a   Olajide, Omolola ^a   Driscoll, Henry ^a   Santanam, Nalini ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pennsylvania Institute of Endocrinology   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Key words: Adiponectin biomarkers inflammation obesity waist hip ratio

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CD40 LIGAND; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN; AUTACOID; BIOLOGICAL MARKER;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; POSTMENOPAUSE; PREMENOPAUSE; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO; AGED; BLOOD; BLOOD PRESSURE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY;

ADIPOKINES; ADULT; AGED; BIOMARKERS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; WAIST-HIP RATIO;

EID: 85030664387     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: 10.23736/S0391-1977.17.02595-0     Document Type: Article

References (34)

1. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief 2013;1-8.
2. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep 2012; 14: 254-60.
3. Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int 2014;2014:406960.
4. Maiolino G, Cesari M, Sticchi D, Zanchetta M, Pedon L, Antezza K, et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 2008; 93: 3333-40.
5. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29:1357-62.
6. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003;26:2442-50.
7. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et al. Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension 2007;49:1455-61.
8. Hui X, Lam KS, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: An update. Br J Pharmacol 2012; 165: 574-90.
9. Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 2010; 425: 41-52.
10. Akishita M, Yu J. Hormonal effects on blood vessels. Hypertens Res 2012;35:363-9.
11. Hart EC, Joyner MJ, Wallin BG, Charkoudian N. Sex, ageing and blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors. J Physiol 2012;590:2069-79.
12. Ogunro PS, Bolarinde AA, Owa OO, Salawu AA, Oshodi AA. Antioxidant status and reproductive hormones in women during reproductive, perimenopausal and postmenopausal phase of life. Afr J Med Med Sci 2014;43:49-57.
13. Sieminska L, Wojciechowska C, Foltyn W, Kajdaniuk D, Kos-Kudla B, Marek B, et al. The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause. Endokrynol Pol 2006;57:15-22.
14. Im JA, Lee JW, Lee HR, Lee DC. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas 2006;54:65-71.
15. Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D, et al. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism 2005; 54: 1610-4.
16. Chedraui P, Escobar GS, Ramirez C, Perez-Lopez FR, Hidalgo L, Mannella P, et al. Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol 2012;28:787-91.
17. Pamukcu B, Lip GY, Snezhitskiy V, Shantsila E. The CD40-CD40L system in cardiovascular disease. Ann Med 2011;43:331-40.
18. Ferroni P, Guadagni F. Soluble CD40Land its role in essential hypertension: diagnostic and therapeutic implications. Cardiovasc Hematol Disord Drug Targets 2008;8:194-202.
19. Bechlioulis A, Naka KK, Kalantaridou SN, Kaponis A, Papanikolaou O, Vezyraki P, et al. Increased vascular inflammation in early menopausal women is associated with hot flush severity. J Clin Endocrinol Metab 2012;97: 760-4.
20. Bechlioulis A, Naka KK, Kalantaridou SN, Chatzikyriakidou A, Papanikolaou O, Kaponis A, et al. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms. Maturitas 2012;71:389-95.
21. Malutan AM, Dan M, Nicolae C, Carmen M. Proinflammatory and anti-inflammatory cytokine changes related to menopause. Prz Menopauzalny 2014;13:162-8.
22. Ertek S, Cicero A. Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 2012;8:794-804.
23. Watson T, Goon PK, Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid Redox Signal 2008;10:1079-88.
24. Tomita H, Egashira K, Kubo-Inoue M, Usui M, Koyanagi M, Shimokawa H, et al. Inhibition of NOsynthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol 1998;18:1456-64.
25. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823-31.
26. Hall N, White C, O'Sullivan AJ. The relationship between adiponectin, progesterone, and temperature across the menstrual cycle. J Endocrinol Invest 2009;32:279-83.
27. Krentz AJ, von Muhlen D, Barrett-Connor E. Adipocytokines, sex hormones, and cardiovascular risk factors in postmenopausal women: factor analysis of the Rancho Bernardo study. Horm Metab Res 2009; 41:773-7.
28. Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008;87:295-302.
29. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
30. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274-8.
31. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M. Sedentary behavior and adiposity-associated inflammation: the Multi-Ethnic Study of Atherosclerosis. Am J Prev Med 2012;42:8-13.
32. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, et al. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab 2011;96:146-50.
33. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-69.
34. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104-10.